More Support for Long-Term Plavix to Improve Stent Safety
December 5th 2006DURHAM, N.C. -- Extending dual antiplatelet therapy with aspirin and Plavix (clopidogrel) to six months or longer significantly reduced the risk of death or myocardial infarction for patients given-drug eluting stents, researchers here reported.
Mortality in Phase III Trial Pulls Plug on HDL-Booster
December 4th 2006CLEVELAND -- The abrupt halt to clinical trials of torcetrapib, an investigational HDL-boosting agent, raises questions about any drug that inhibit cholesteryl ester transfer protein (CETP), according to cardiologist Steven Nissen, M.D., of the Cleveland Clinic.
Older Schizophrenia Drug Called More Cost-Effective Than Newer Ones
December 1st 2006NEW YORK -- The older antipsychotic drug, Trilafon (perphenazine), is significantly cheaper and no less effective than four newer medications for the treatment of chronic schizophrenia, according to researchers here.
Sorting Out the Complexities of an Elderly Woman's Fall
December 1st 2006I enjoyed Dr Henry Schneiderman’s “What’s Your Diagnosis?” case of an elderly woman with severe facial ecchymoses from a fall. Would Dr Schneiderman elaborate on several points about that case? This woman did not trip or complain of dizziness before she fell. What caused her to fall?
Clinical Citations: Noninvasive ventilation benefits patients with acute pulmonary edema
December 1st 2006Because of the potential complications associated with mechanical ventilation, noninvasive ventilation is considered an attractive alternative in some settings. How useful is it in patients with acute cardiogenic pulmonary edema? Researchers who addressed this question found that the early application of noninvasive ventilation in the emergency department (ED) can decrease the relative risk of mortality by 39% and the need for endotracheal intubation by 57%.
Clinical Citations: Managing acute VTE: Is SQ unfractionated heparin an option?
December 1st 2006A major disadvantage of unfractionated heparin is its intravenous administration and the need for coagulation monitoring and hospitalization. However, subcutaneous administration may be an alternative, according to Kearon and coworkers. They found that fixed-dose subcutaneous unfractionated heparin appears to be as effective and safe as low molecular weight heparin (LMWH) for the outpatient treatment of acute venous thromboembolism (VTE).